Skip to main content

Table 1 Characteristics of patients, and distribution of Pneumococcal isolates during the study period

From: Serotypes distribution and antibiotic susceptibility of Streptococcus pneumoniae strains: five-year surveillance results of post-PCV-13

 

Invasive n (%)

Non-invasive n (%)

2011

2012

2013

2014

2015

Total

2011

2012

2013

2014

2015

Total

No of isolates

1 (0.2)

10 (2.4)

9 (2.1)

4

(1)

19 (4.5)

43 (10.2)

17 (4)

48 (11.4)

31 (7.4)

67 (16)

214 (51)

377 (89.8)

No of patients

1 (0.3)

10 (2.8)

8 (2.2)

4 (1.1)

17 (4.8)

40 (11.2)

14 (3.9)

40 (11.2)

26 (7.3)

57 (16)

179 (50.3)

316 (88.8)

Age groups of patient

  

0–24 months

0

(0)

1 (0.3)

1 (0.3)

1 (0.3)

4 (1.1)

7

(2)

1 (0.3)

1 (0.3)

1 (0.3)

7

(2)

24 (6.7)

34 (9.6)

25–59 months

0

(0)

0

(0)

1 (0.3)

0

(0)

1 (0.3)

2 (0.6)

1 (0.3)

1 (0.3)

3 (0.8)

0

(0)

14 (3.9)

19 (5.3)

5–18 years

1 (0.3)

2 (0.6)

1 (0.3)

2 (0.6)

3 (0.8)

9 (2.5)

9 (2.5)

18

(5)

12 (3.4)

23 (6.5)

67 (18.8)

129 (36.2)

19–65 years

0

(0)

4 (1.1)

5 (1.4)

1 (0.3)

4 (1.1)

14 (3.9)

2 (0.6)

16 (4.5)

8 (2.2)

23 (6.5)

47 (13.2)

96 (27)

>65 years

0

(0)

3 (0.8)

0

(0)

0

(0)

5 (1.4)

8 (2.2)

1 (0.3)

4 (1.1)

2 (0.6)

4 (1.1)

27 (7.6)

38 (10.7)

Comorbidities

  

No comorbidity

0

(0)

2 (0.6)

5 (1.4)

2 (0.6)

7

(2)

16 (4.5)

4 (1.1)

5 (1.4)

5 (1.4)

20 (5.6)

60 (16.9)

94 (26.4)

Asthma

0

(0)

0

(0)

0

(0)

0

(0)

0

(0 )

0

(0)

2 (0.6)

7

(2)

6 (1.7)

10 (2.8)

38 (10.6)

63 (17.7)

Bronchiectasis

0

(0)

1 (0.3)

0

(0)

0

(0)

0

(0)

1 (0.3)

2 (0.6)

8 (2.2)

6 (1.7)

5 (1.4)

24 (6.7)

45 (12.6)

Malignancy

0

(0)

3 (0.8)

1 (0.3)

1 (0.3)

2 (0.6)

7

(2)

0

(0)

6 (1.7)

2 (0.6)

3 (0.8)

10 (2.8)

21 (5.9)

Cystic fibrosis

0

(0)

0

(0)

0

(0)

0

(0)

0

(0)

0

(0)

1 (0.3)

3 (0.8)

2 (0.6)

3 (0.8)

18 (5.1)

27 (7.6)

Immunodeficiencies

0

(0)

2 (0.6)

0

(0)

0

(0)

0

(0)

2 (0.6)

0

(0)

3 (0.8)

4 (1.1)

8 (2.2)

7

(2)

22 (6.2)

Others

1 (0.3)

2 (0.6)

2 (0.6)

1 (0.3)

8 (2.2)

14 (3.9)

5 (1.4)

8 (2.2)

1 (0.3)

8 (2.2)

22 (6.3)

44 (12.4)